| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.430 | 14.593 | 14.023 | 52.007 | 24.851 | 29.080 | 29.910 | 40.296 | 50.955 |
| Total Income - EUR | - | 4.430 | 14.593 | 14.023 | 52.018 | 26.634 | 29.080 | 29.915 | 40.304 | 50.958 |
| Total Expenses - EUR | - | 3.411 | 17.983 | 17.277 | 40.838 | 25.638 | 24.167 | 28.645 | 33.289 | 49.483 |
| Gross Profit/Loss - EUR | - | 1.019 | -3.390 | -3.254 | 11.180 | 996 | 4.912 | 1.271 | 7.016 | 1.475 |
| Net Profit/Loss - EUR | - | 960 | -3.536 | -3.396 | 10.657 | 762 | 4.645 | 1.047 | 6.633 | 130 |
| Employees | - | 2 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Ozonis Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 691 | 600 | 1.509 | 4.475 | 3.647 | 8.841 | 7.152 | 5.641 | 15.738 |
| Current Assets | - | 3.046 | 237 | 845 | 25.234 | 17.778 | 17.862 | 15.625 | 31.448 | 21.250 |
| Inventories | - | 1.431 | 0 | 0 | 3.765 | 4.075 | 3.961 | 2.591 | 11.014 | 9.821 |
| Receivables | - | 0 | 186 | 758 | 10.855 | 1.855 | 2.922 | 1.805 | 4.670 | 246 |
| Cash | - | 1.616 | 51 | 87 | 10.614 | 11.847 | 10.979 | 11.229 | 15.764 | 11.183 |
| Shareholders Funds | - | 1.005 | -2.548 | -5.897 | 15.097 | 15.573 | 19.872 | 20.981 | 24.844 | 20.814 |
| Social Capital | - | 45 | 44 | 43 | 10.265 | 10.070 | 9.847 | 9.877 | 9.847 | 9.792 |
| Debts | - | 2.733 | 3.386 | 8.251 | 14.613 | 5.852 | 6.831 | 1.796 | 12.245 | 16.175 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Ozonis Med S.r.l.